Carla Montironi
Overview
Explore the profile of Carla Montironi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sisuashvili L, Saco A, Carreras-Dieguez N, Celada C, Marimon L, Montironi C, et al.
Int J Gynecol Pathol
. 2025 Feb;
44(2):120-124.
PMID: 39928484
Vulvar squamous cell carcinoma (VSCC) can be classified according to human papillomavirus (HPV) status as HPV-associated (HPV-A) and HPV-independent (HPV-I). However, a small subset of tumors may show overlapping features...
2.
Cappuyns S, Pique-Gili M, Esteban-Fabro R, Philips G, Balaseviciute U, Pinyol R, et al.
J Hepatol
. 2024 Dec;
PMID: 39709141
Background & Aims: The combination of atezolizumab and bevacizumab (atezo+bev) is the current standard of care for advanced hepatocellular carcinoma (HCC), providing a median overall survival (OS) of 19.2 months....
3.
Pique-Gili M, Andreu-Oller C, Mesropian A, Esteban-Fabro R, Barcena-Varela M, Ruiz de Galarreta M, et al.
JHEP Rep
. 2024 Nov;
6(11):101212.
PMID: 39524206
Background & Aims: Transforming growth factor β (TGF-β) plays an oncogenic role in advanced cancer by promoting cell proliferation, metastasis and immunosuppression. (prostate transmembrane protein androgen induced 1) has been...
4.
Castrejon N, Martin R, Carrasco A, Castillo P, Garcia A, Albero-Gonzalez R, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000050
Targeted NGS allows a fast and efficient multi-gene analysis and the detection of key gene aberrations in melanoma. In this study, we aim to describe the genetic alterations in a...
5.
Moysset I, Castrejon N, Garcia-Herrera A, Castillo P, Marginet M, Teixido C, et al.
Histopathology
. 2024 Feb;
84(7):1154-1166.
PMID: 38409889
Aims: The current WHO classification of melanocytic tumours excludes neoplasms showing BRAF or NRAS mutations from the Spitz category. This study aimed to review and reclassify atypical melanocytic tumours with...
6.
Olivas P, Perez-Campuzano V, Orts L, Montironi C, Magaz M, Ruiz P, et al.
JHEP Rep
. 2024 Feb;
6(3):100996.
PMID: 38384671
Background & Aims: Porto-sinusoidal vascular disorder (PSVD) encompasses a group of liver diseases with vascular abnormalities that can cause portal hypertension in the absence of cirrhosis. The new diagnostic criteria...
7.
Gratacos-Gines J, Avitabile E, Montironi C, Guillamon-Thiery A, Hernandez-Evole H, Moreta M, et al.
Clin Gastroenterol Hepatol
. 2023 Dec;
22(4):768-777.e8.
PMID: 38065374
Background & Aims: Alcoholic foamy degeneration (AFD) is a condition with similar clinical presentation to alcohol-associated hepatitis (AH), but with a specific histologic pattern. Information regarding the prevalence and prognosis...
8.
Castillo P, Castrejon N, Marginet M, Massi D, Alamon F, Teixido C, et al.
Clin Exp Dermatol
. 2023 Nov;
49(4):356-363.
PMID: 37995304
Background: A combined deep-penetrating tumour redefined as WNT-activated deep-penetrating/plexiform melanocytoma (DPM), may pose challenging clinical and histological diagnoses. Objectives: To review the clinicopathological characteristics of combined DPMs and characterize the...
9.
Camprecios G, Vilaseca M, Tripathi D, Montironi C, Diaz A, Aguilar D, et al.
Liver Int
. 2023 Oct;
44(1):180-190.
PMID: 37872644
Background: Porto-sinusoidal vascular disorder (PSVD) involves a group of rare vascular liver diseases of unknown aetiology that may lead to the development of portal hypertension and its life-threatening complications. Its...
10.
Nunez-Pizarro J, Toapanta D, Montironi C, Zapatero J
J Hepatol
. 2023 Oct;
79(5):e182-e184.
PMID: 37863546
No abstract available.